2EyesVision secures an investment from Bullnet Capital

The investors believe in the first technology ever allowing presbyopic and cataract patients to experience the real world through multifocal corrections

The company has developed SimVis, the first technology ever allowing presbyopic and cataract patients to experience the real world through multifocal corrections before intraocular lens implantation, refractive surgery, or contact lens fitting. The investment will allow the company to release a first version of the product and start its commercialization.

2EyesVision, spinoff of the Visual Optics and Biophotonics Laboratory of the Spanish National Research Council (CSIC) has announced today a Series A investment led by Bullnet Capital. The investment will provide the company with the necessary resources to strengthen product development and to create a sales and marketing structure.

The SimVis technology is the result of a 7 year investigation and it allows cataract and presbyopic patients to experience, for the first time, the real world through multifocal corrections before contact lens fitting and intraocular lenses  implantation, allowing the ophthalmologist to take a personalized decision on the lens to be implanted based on the patient’s preferences.

Dr. Iñigo Jiménez Alfaro, Head of the Ophthalmology Service at Fundación Jiménez Díaz: “With several million people affected by these ocular conditions, the impact of SimVis is enormous. The availability of SimVis in the clinic reduces  uncertainty both for the clinician and for the patient and decreases the number of patients dissatisfied or with undesired visual phenomena. In addition, from a scientific point of view, SimVis allows to design and validate new corrections that adapt to the needs of patients” Said

Bullnet Capital​

Bullnet Capital is a venture capital firm based in Madrid, Spain. The firm focuses on investing in early-stage startups in Spain and Latin America, particularly those operating in the technology, internet, and mobile sectors.

According to Javier Ulecia from Bullnet Capital: “2EyesVision is a company completely in line with our investment criteria: a team with proven experience in the technology world with patent-protected products, capable of creating new technologies and to develop an effective commercial strategy at a global level in sectors with growing demand.”